January 30, 2026 · Form 4 insider transaction
Urist Marshall sold 20,000 shares of Royalty Pharma plc at $41.09 per share, a transaction worth $821.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on September 16, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.88 to $41.28 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.